Sign in

Aigen Investment Management, LP

CIK:0001741224
Hedge Fund
$159M AUM
750 holdings
New York, NY, United States
Founded:2019
8 employees
Latest filing:Jun 30, 2025

Aigen Investment Management, LP is a hedge fund headquartered in New York, NY, United States. Founded in 2019, the firm manages pooled investment vehicles primarily for institutional clients. As of March 2025, Aigen manages assets under management (AUM) of approximately $158.5 million and employs 8 staff, predominantly investors. Aigen is SEC-registered and focuses on U.S. equities.

Investment Strategy

Aigen Investment Management, LP pursues actively managed investment strategies, primarily focusing on long and short positions within U.S. equities across various sectors. The firm discloses diverse holdings and regularly engages in portfolio rebalancing, targeting both large-cap and mid-cap stocks. The fund manages capital for pooled investment vehicles, using discretionary investment authority to seek risk-adjusted returns for its clients.

Top Buys
A
APHAMPHENOL CORP NEW
+$9.2M
U
UNPUNION PAC CORP
+$6.4M
M
MCDMCDONALDS CORP
+$5.7M
F
FIFISERV INC
+$5.5M
O
ORCLORACLE CORP
+$5.5M
Top Sells
A
AONAON PLC
-$6.1M
U
USBUS BANCORP DEL
-$5.8M
A
AMATAPPLIED MATLS INC
-$4.9M
O
OXYOCCIDENTAL PETE CORP
-$4.4M
C
CSXCSX CORP
-$3.7M

Top Holdings

A
APHAMPHENOL CORP NEW
+1.3%$9.2M
B
BSXBOSTON SCIENTIFIC CORP
+1.0%$7.3M
H
HONHONEYWELL INTL INC
+0.9%$6.5M
U
UNPUNION PAC CORP
+0.9%$6.4M
A
ABBVABBVIE INC
+0.8%$6.0M

Equity Positions (744)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
A
APH
AMPHENOL CORP NEW1.26%$9.2M93,074$98.75$98.75+$9.2M
B
BSX
BOSTON SCIENTIFIC CORP1.01%$7.3M68,321$101.22$107.41+$800.1K
H
HON
HONEYWELL INTL INC0.89%$6.5M27,923$220.97$232.88+$3.2M
U
UNP
UNION PAC CORP0.87%$6.4M27,739$230.08$230.08+$6.4M
A
ABBV
ABBVIE INC0.82%$6.0M32,333$187.59$185.62+$5.4M

Industry Allocation

SERVICES-PREPACKAGED SOFTWARE
+7.5%
SERVICES-BUSINESS SERVICES, NEC
+3.8%
PHARMACEUTICAL PREPARATIONS
+3.8%
NATIONAL COMMERCIAL BANKS
+2.3%
SEMICONDUCTORS & RELATED DEVICES
+2.3%